Lymphangioleiomyomatosis treatment with sirolimus;Tratamiento de la linfangioleiomiomatosis con sirolimus

Archivos de Bronconeumologia

Volumn 47, Issue 9, 2011, Pages 470-472

  Casanova, Álvaro ^a   María Girón, Rosa ^b   Acosta, Orlando ^c   Barrón, Manuel ^d   Valenzuela, Claudia ^b   Ancochea, Julio ^b  

^a Refractive Surgeon at Clínica Baviera Madrid   (Spain)

^b Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa   (Spain)

^c HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^d HOSPITAL SAN PEDRO   (Spain)

Author keywords

Lynphangioleiomyomatosis; Sirolimus; Tuberous sclerosis

Indexed keywords

RAPAMYCIN;

ARTICLE; CASE REPORT; FEMALE; HUMAN; LUNG FUNCTION; LYMPHANGIOLEIOMYOMATOSIS; RESPIRATORY FAILURE; SYMPTOMATOLOGY;

EID: 80052431649     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2011.01.007     Document Type: Article

References (13)

1. Johnson S.R. Lymphangioleiomyomatosis. Eur Respir J 2006, 27:1056-1065.
2. McCarty K.S., Mossler J.A., McLelland R., Sieker H.O. Pulmonary lymphangioleiomyomatosis responsive to progesterone. N Engl J Med. 1980, 303:1461-1465.
3. Eliasson A.H., Phillips Y.Y., Tenholder M.F. Treatment of lymphangioleiomyomatosis. A meta-analysis. Chest. 1989, 96:1352-1355.
4. Taveira-DaSilva A.M., Stylianou M.P., Hedin C.J., Hathaway O., Moss J. Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone. Chest. 2004, 126:1867-1874.
5. Johnson S.R., Cordier J.F., Lazor R., Cottin V., Costabel U., Harari S., et al. European Respiratory Society guidelines for the diagnosis and management of lymphangioleyomiomatosis. Eur Respir J. 2010, 35:14-26.
6. Crino P.B., Nathanson K.L., Henske E.P. The tuberous sclerosis complex. N Engl J Med. 2006, 355:1345-1356.
7. Kpodonu J., Massad M.G., Chaer R.A., Caines A., Evans A., Snow N.J., et al. The US experience with lung transplantation for pulmonary lymphangioleyomiomatosis. J Heart Lung Transplant. 2005, 24:1247-1253.
8. Goncharova E.A., Goncharov D.A., Eszterhas A., Hunter D.S., Glassberg M.K., Yeung R.S., et al. Tuberin regulates p70 S6 activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatoisis (LAM). J Biol Chem. 2002, 277:30958-30967.
9. Astrinidis A., Khare L., Carsillo T., Smolarek T., Au K.S., Northrup H., et al. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis. J Med Genet. 2000, 37:55-57.
10. Lee L., Sudentas P., Donohue B., Asrican K., Worku A., Walker V., et al. Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models. Genes Chromosomes Cancer. 2005, 42:213-227.
11. Antón E., Casanova A., Xaubet A., Román A., Villena V., Montero M.C., et al. Lymphangioleiomyomatosis: a study of 72 patients from the Spanish registry. Sarcoidosis Vasc Diffuse Lung Dis. 2009, 26:85-91.
12. Herry I., Neukirch C., Debray M.P., Mignon F., Crestani B. Dramatic effect of sirolimus on renal angiomyolipomas in a patient with tuberous sclerosis complex. Eur J Intern Med. 2007, 18:76-77.
13. Bissler J.J., McCormack F.X., Young L.R., Elwing J.M., Chuck G., Leonard J.M., et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med. 2008, 358:140-151.